AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 268 filers reported holding AMEDISYS INC in Q3 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $637,184 | -5.5% | 6,941 | -5.2% | 0.02% | -4.3% |
Q1 2024 | $674,519 | -3.1% | 7,319 | 0.0% | 0.02% | -8.0% |
Q4 2023 | $695,744 | +1.8% | 7,319 | 0.0% | 0.02% | -7.4% |
Q3 2023 | $683,595 | -8.1% | 7,319 | -10.1% | 0.03% | -3.6% |
Q2 2023 | $744,047 | -38.5% | 8,137 | -50.5% | 0.03% | -41.7% |
Q1 2023 | $1,209,383 | +51.2% | 16,443 | +97.1% | 0.05% | +50.0% |
Q4 2022 | $799,760 | -49.1% | 8,343 | -48.6% | 0.03% | -54.3% |
Q3 2022 | $1,571,000 | -3.1% | 16,243 | +5.2% | 0.07% | 0.0% |
Q2 2022 | $1,622,000 | -39.0% | 15,444 | 0.0% | 0.07% | -27.1% |
Q1 2022 | $2,660,000 | +6.4% | 15,444 | 0.0% | 0.10% | +14.3% |
Q4 2021 | $2,499,000 | +8.6% | 15,444 | 0.0% | 0.08% | 0.0% |
Q3 2021 | $2,302,000 | -39.8% | 15,444 | -1.0% | 0.08% | -38.7% |
Q2 2021 | $3,821,000 | -13.1% | 15,604 | -1.7% | 0.14% | -18.5% |
Q1 2021 | $4,395,000 | -5.6% | 15,868 | 0.0% | 0.17% | -21.1% |
Q4 2020 | $4,654,000 | +23.1% | 15,868 | -0.8% | 0.21% | +24.6% |
Q3 2020 | $3,780,000 | +17.8% | 15,992 | -1.1% | 0.17% | +11.8% |
Q2 2020 | $3,210,000 | -6.1% | 16,167 | -13.2% | 0.15% | -21.1% |
Q1 2020 | $3,419,000 | +9.9% | 18,629 | -0.0% | 0.19% | +40.6% |
Q4 2019 | $3,111,000 | +19.9% | 18,638 | -5.9% | 0.14% | +16.0% |
Q3 2019 | $2,595,000 | +10.5% | 19,808 | +2.4% | 0.12% | +11.2% |
Q2 2019 | $2,348,000 | +76.7% | 19,339 | +79.4% | 0.11% | +72.6% |
Q1 2019 | $1,329,000 | +411.2% | 10,780 | +385.6% | 0.06% | +342.9% |
Q4 2018 | $260,000 | -0.8% | 2,220 | +6.0% | 0.01% | +16.7% |
Q3 2018 | $262,000 | +34.4% | 2,095 | -8.2% | 0.01% | +33.3% |
Q2 2018 | $195,000 | +33.6% | 2,281 | -5.5% | 0.01% | +28.6% |
Q1 2018 | $146,000 | +15.0% | 2,415 | 0.0% | 0.01% | +16.7% |
Q4 2017 | $127,000 | +0.8% | 2,415 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $126,000 | -17.1% | 2,415 | 0.0% | 0.01% | -14.3% |
Q2 2017 | $152,000 | +23.6% | 2,415 | 0.0% | 0.01% | +16.7% |
Q1 2017 | $123,000 | – | 2,415 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
RK Capital | 54,900 | $9,459,000 | 1.86% |
Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |